Celestra

Drug discovery is accelerating. AI is helping researchers develop new treatments faster than ever.

Soon, we believe the bottleneck won't be discovery - it will be commercialization.

As more drugs pass FDA approval, slow and manual commercialization operations will become the limiting factor. Today, market research takes months, patient identification is imprecise, and commercial strategy relies on outdated data and consultant-driven intuition.

We're building AI agents to automate drug commercialization so new treatments reach patients faster.

Autonomous agents for commercialization

Our agents tackle the core problems that delay launch and adoption:

• Market analysis: Real-time competitive and market intelligence
• Patient identification: Faster, more accurate targeting using claims and EHR data
• Commercial strategy: Data-driven pricing, positioning, and go-to-market decisions
• Regulatory insights: Smarter navigation of approval and launch requirements

Built for teams

We don't replace commercial teams - we amplify them.

Our agents help teams:

• Make decisions in hours, not weeks
• Replace static reports with live, data-driven insight
• Scale world-class commercial expertise across the organization

We build alongside pharma and biotech teams to solve real-world bottlenecks.

Join us

If you want to help remove the barriers that keep treatments from reaching patients, we'd love to talk.